Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.2800 (-2.36%) ($2.2800 - $2.2800) on Tue. May. 3, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.8% (three month average) | RSI | 32 | Latest Price | $2.2800(-2.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.4% a day on average for past five trading days. | Weekly Trend | CGEN declines -5.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) BLOK(99%) IBB(99%) URA(99%) IBUY(95%) VT(95%) | Factors Impacting CGEN price | CGEN will decline at least -1.9% in a week (0% probabilities). UUP(-11%) SHY(-4%) TIP(-3%) BNDX(11%) USO(17%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.9% (StdDev 3.8%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-18.66(-918.42%) | Resistance Level | $2.6 | 5 Day Moving Average | $2.35(-2.98%) | 10 Day Moving Average | $2.39(-4.6%) | 20 Day Moving Average | $2.6(-12.31%) | To recent high | -33.9% | To recent low | 0% | Market Cap | $189m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |